PHARMACOKINETIC STUDY OF RECAINAM, A NEW CLASS-I ANTIARRHYTHMIC AGENT

被引：0
|
作者：
CAPUZZI, DM [1 ]
FRIEDMAN, J [1 ]
ROGERS, SL [1 ]
CHIANG, ST [1 ]
KNOWLES, JA [1 ]
DEITCH, MW [1 ]
机构：
[1] WYETH LABS INC,PHILADELPHIA,PA 19101
来源：
CLINICAL RESEARCH | 1987年 / 35卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A9 / A9
页数：1
相关论文
共 50 条
  • [21] EFFECTS OF CLASS-I ANTIARRHYTHMIC DRUGS IN INFARCTED TISSUE
    MAN, RYK
    BRIL, A
    CLINICAL AND INVESTIGATIVE MEDICINE, 1991, 14 (05): : 466 - 475
  • [22] THE PHARMACOKINETICS OF INTRAVENOUS RECAINAM HCL, A POTENT NEW CLASS-I ANTIDYSRHYTHMIC, IN PATIENTS WITH FREQUENT PREMATURE VENTRICULAR CONTRACTIONS
    HAMPTON, EM
    ANASTASIOUNANA, MI
    NANAS, JN
    MARBLE, D
    ANDERSON, JL
    CLINICAL RESEARCH, 1986, 34 (01): : A89 - A89
  • [23] ELECTROPHYSIOLOGIC EFFECTS OF RECAINAM - A NEW ANTIARRHYTHMIC DRUG
    VOLOSIN, KJ
    JEFFERIES, LS
    GREENSPONJEFFERSON, AJ
    CLINICAL RESEARCH, 1986, 34 (03): : A865 - A865
  • [24] ELECTROPHYSIOLOGIC EFFECTS OF A NEW ANTIARRHYTHMIC AGENT, RECAINAM, ON ISOLATED CANINE AND RABBIT MYOCARDIAL FIBERS
    TAKIKAWA, R
    KAMIYA, K
    KATO, R
    SINGH, BN
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 11 (04) : 875 - 881
  • [25] ELECTROPHYSIOLOGIC PROFILE OF RECAINAM, A NEW ANTIARRHYTHMIC AGENT, DETERMINED BY INTRACARDIAC ELECTROPHYSIOLOGIC MEASUREMENTS IN MAN
    MYERBURG, RJ
    LUCERI, RM
    HOROWITZ, LN
    SINGH, B
    GREENSPON, A
    KOWEY, P
    FRIEDMAN, J
    CAPUZZI, DM
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1987, 10 (04): : 993 - 993
  • [26] IS THERE AN IDEAL ANTIARRHYTHMIC DRUG A REVIEW - WITH PARTICULAR REFERENCE TO CLASS-I ANTIARRHYTHMIC AGENTS
    MUHIDDIN, KA
    TURNER, P
    POSTGRADUATE MEDICAL JOURNAL, 1985, 61 (718) : 665 - 678
  • [27] A PLACEBO-CONTROLLED STUDY OF THE PROARRHYTHMIC EFFECTS OF CLASS-I ANTIARRHYTHMIC DRUGS
    BIGGER, T
    WOOSLEY, R
    RODEN, D
    HALLSTROM, A
    ECHT, D
    GREENE, L
    BUTLER, L
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (02) : A245 - A245
  • [28] VALUE AND RISK OF CLASS-I AND CLASS-III ANTIARRHYTHMIC DRUGS
    BURKART, F
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1994, 17 (03): : 467 - 472
  • [29] Ro 22-9194: A new Class I antiarrhythmic agent
    Murakami, M
    Furukawa, Y
    Nakashima, M
    Chiba, S
    CARDIOVASCULAR DRUG REVIEWS, 1996, 14 (01): : 47 - 59
  • [30] INFLUENCE OF THE NEW CLASS-I ANTIARRHYTHMIC AGENT DIPRAFENONE ON THE END-SYSTOLIC PRESSURE-VOLUME RELATIONSHIP (CONDUCTANCE TECHNIQUE)
    THORMANN, J
    KRAMER, W
    KREMER, P
    SCHLEPPER, M
    CARDIOVASCULAR DRUGS AND THERAPY, 1989, 3 (02) : 145 - 154
12345